Inventor · disambiguated record
Andrea Pfeifer
Also filed as: PFEIFER ANDREA · PFEIFER ANDREA M · PFEIFER ANDREA M A
43 granted patents·32 pending applications·662 citations·filing 1992–2025
98Inventor score
Top patents by PatentIndex Score
75 records- 0197US7892544B2Humanized anti-beta-amyloid antibodyAC IMMUNE SA·Filed 2007·Granted Feb 22, 2011·55 cites·26 claims
- 0296US7772375B2Monoclonal antibodies that recognize epitopes of amyloid-betaAC IMMUNE SA·Filed 2006·Granted Aug 10, 2010·51 cites·15 claims
- 0394US9585956B2Polynucleotides encoding anti-amyloid beta monoclonal antibodiesAC IMMUNE SA·Filed 2015·Granted Mar 7, 2017·8 cites·21 claims
- 0494US8246954B2Methods of treating amyloidosis with humanized anti-beta-amyloid antibodiesPFEIFER ANDREA·Filed 2009·Granted Aug 21, 2012·24 cites·57 claims
- 0594US6399381B1Serum-free culture medium for immortalized human colon epithelial cell lineNESTEC SA·Filed 2000·Granted Jun 4, 2002·61 cites·8 claims
- 0693US9175094B2Monoclonal antibodyAC IMMUNE SA·Filed 2013·Granted Nov 3, 2015·9 cites·36 claims
- 0793US8124353B2Methods of treating and monitoring disease with antibodiesPFEIFER ANDREA·Filed 2007·Granted Feb 28, 2012·20 cites·11 claims
- 0892US8796439B2Nucleic acid molecules encoding a humanized antibodyPFEIFER ANDREA·Filed 2012·Granted Aug 5, 2014·15 cites·47 claims
- 0991US8647631B2Pharmaceutical composition of an antigenic tau peptide reconstituted in a liposome and related antibodies and cell linesPFEIFER ANDREA·Filed 2010·Granted Feb 11, 2014·16 cites·15 claims
- 1090US11530263B2IL-18 binding protein (IL-18BP) in inflammatory diseasesAB2 BIO SA·Filed 2020·Granted Dec 20, 2022·2 cites·18 claims
- 1190US8048420B2Monoclonal antibodyAC IMMUNE SA·Filed 2008·Granted Nov 1, 2011·12 cites·36 claims
- 1288US9304138B2Pharmaceutical compositionPFEIFER ANDREA·Filed 2011·Granted Apr 5, 2016·12 cites·27 claims
- 1387US11684576B2Method of safe administration of phosphorylated tau peptide vaccineAC IMMUNE SA·Filed 2020·Granted Jun 27, 2023·2 cites·20 claims
- 1485US8613923B2Monoclonal antibodyPFEIFER ANDREA·Filed 2008·Granted Dec 24, 2013·7 cites·12 claims
- 1585US7807175B2Therapeutic vaccineAC IMMUNE SA·Filed 2006·Granted Oct 5, 2010·8 cites·45 claims
- 1685US6399124B1Frozen dessert containing lactic acid bacteriaNESTEC SA·Filed 1999·Granted Jun 4, 2002·67 cites·26 claims
- 1784US10100104B2Methods of diagnosing tau-protein-associated diseaseUNIV LEUVEN KATH·Filed 2016·Granted Oct 16, 2018·4 cites·26 claims
- 1884US10066010B2Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising TauAC IMMUNE SA·Filed 2016·Granted Sep 4, 2018·4 cites·14 claims
- 1984US9403902B2Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibodyPFEIFER ANDREA·Filed 2008·Granted Aug 2, 2016·7 cites·9 claims
- 2084US9146244B2Polynucleotides encoding an anti-beta-amyloid monoclonal antibodyPFEIFER ANDREA·Filed 2011·Granted Sep 29, 2015·6 cites·37 claims
- 2184US7294509B2Pre-adipose cell linesNESTEC SA·Filed 2003·Granted Nov 13, 2007·18 cites·12 claims
- 2282US9540434B2Phosphospecific antibodies recognising tauAC IMMUNE SA·Filed 2012·Granted Jan 10, 2017·5 cites·17 claims
- 2381US9657091B2Humanized tau antibodyAC IMMUNE SA·Filed 2013·Granted May 23, 2017·5 cites·22 claims
- 2481US5529920AHuman liver epithelial cell line and culture media thereforUS HEALTH·Filed 1992·Granted Jun 25, 1996·72 cites·22 claims
- 2579US12324855B2Method of safe administration of phosphorylated Tau peptide vaccineAC IMMUNE SA·Filed 2023·Granted Jun 10, 2025·0 cites·20 claims
- 2679US10858426B2IL-18 binding protein (IL-18BP) in inflammatory diseasesAB2 BIO SA·Filed 2014·Granted Dec 8, 2020·2 cites·5 claims
- 2779US8603487B2Palmitoylated AB 1-15 in a liposome as a treatment for amyloid associated diseasesPFEIFER ANDREA·Filed 2009·Granted Dec 10, 2013·3 cites·23 claims
- 2879US2023338535A1Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune ResponsesJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2978US9687447B2Method for preparing liposome-based constructsREIS PEDRO·Filed 2011·Granted Jun 27, 2017·8 cites·3 claims
- 3078US9598485B2Anti-tau antibodies and methods of useAC IMMUNE SA·Filed 2014·Granted Mar 21, 2017·4 cites·66 claims
- 3178US7588781B2Method for increasing bioavailability of lipophilic bioactive compoundsNESTEC SA·Filed 2006·Granted Sep 15, 2009·3 cites·17 claims
- 3276US9221900B2Methods for identifying safe and functional humanized antibodiesPFEIFER ANDREA·Filed 2011·Granted Dec 29, 2015·3 cites·26 claims
- 3376US6949381B2Immortalized human skin cell lines and novel serum-free medium useful for the production thereofNESTEC SA·Filed 2001·Granted Sep 27, 2005·4 cites·16 claims
- 3475US9701660B22,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual systemAC IMMUNE SA·Filed 2014·Granted Jul 11, 2017·2 cites·8 claims
- 3575US2025134973A1Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune ResponsesJANSSEN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3674US6395542B1Immortalized human colon epithelial cell lineNESTEC SA·Filed 2000·Granted May 28, 2002·3 cites·6 claims
- 3774US5356806AImmortalized human cell lines containing exogenous cytochrome P450US HEALTH·Filed 1992·Granted Oct 18, 1994·36 cites·3 claims
- 3873US8916590B22,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual systemKROTH HEIKO·Filed 2010·Granted Dec 23, 2014·2 cites·13 claims
- 3973US2025275920A1Method of Safe Administration of Phosphorylated TAU Peptide VaccineAC IMMUNE SA·Filed 2025·Application pending·0 cites
- 4073US2023250164A1IL-18 Binding Protein (IL-18BP) In Inflammatory DiseasesAB2 BIO SA·Filed 2022·Application pending·0 cites
- 4170US8455004B2Primary composition comprising a lipophilic bioactive compoundBORTLIK KARLHEINZ·Filed 2009·Granted Jun 4, 2013·1 cites·13 claims
- 4269US5506131AImmortalized human cell lines containing exogenous cytochrome P450 genesUS HEALTH·Filed 1993·Granted Apr 9, 1996·27 cites·11 claims
- 4368US2010297132A1Monoclonal antibodyAC IMMUNE SA·Filed 2009·Application pending·0 cites
- 4467US2021317197A1Humanized antibodyAC IMMUNE SA·Filed 2020·Application pending·0 cites
- 4567US2025144212A1Liposomes containing phosphorylated tau peptides for inducing sustained immune responsesJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4667US2024270829A1Vaccine TherapyAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 4766US6194203B1Immortalized adult human colon epithelial cell lineNESTEC SA·Filed 1997·Granted Feb 27, 2001·18 cites·14 claims
- 4865US5660986AImmortalized human cell lines containing exogenous cytochrome P450 genesUS HEALTH·Filed 1995·Granted Aug 26, 1997·18 cites·11 claims
- 4965US2022227847A1Humanized antibodyAC IMMUNE SA·Filed 2021·Application pending·0 cites
- 5064US2020055928A1Humanized antibodyAC IMMUNE SA·Filed 2019·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →